PMID: 11906981Mar 22, 2002Paper

Effects of guided written disclosure of stressful experiences on clinic visits and symptoms in frequent clinic attenders

Family Practice
Yori GidronPesach Shvartzman

Abstract

Psychosocial variables such as major stressful life events/daily stressful events have been associated with health care utilization. Our aim was to examine the effects of a guided disclosure protocol (GDP) of past traumas on symptoms and clinic visits among frequent clinic attenders. Forty-one frequent clinic attenders (> or =2 visits/3 months) took part. Patients were randomly assigned individually to either a casual content writing control group (n = 19) or a trauma content writing experimental GDP group (n = 22). GDP patients wrote about an upsetting event chronologically (day 1), verbally described their thoughts and feelings and described the event's impact on life (day 2), and finally wrote about their current perspective on and future coping with the event (day 3). Three months later, patients were reassessed blindly for symptoms and clinic visits, and an average of 15 months later they were assessed blindly for clinic visits again. Compared with controls, GDP patients reported lower symptom levels at 3 months (2.3 versus 5.2), and made fewer clinic visits during the 3 (1.3 versus 3.0) and 15 month (5.1 versus 9.7) follow-ups. The percentage of GDP patients making > or =10 visits during the 15 month follow-up was smaller...Continue Reading

Citations

Jan 20, 2006·AIDS and Behavior·Inna D RivkinDorothy Chin
May 19, 2005·Journal of Immigrant Health·Tillman FarleyMaria de Jesus Diaz Perez
May 3, 2006·Journal of Consulting and Clinical Psychology·Alex H S Harris
Aug 26, 2009·Anxiety, Stress, and Coping·Sharon Danoff-BurgJohn D Agee
Jun 15, 2007·The Gerontologist·Corey S MackenzieDavid Goldstein
Sep 16, 2006·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Mazy E GillisTimothy Roehrs
Dec 31, 2008·The Journal of the American Academy of Psychoanalysis and Dynamic Psychiatry·Eugenio M Rothe
Oct 20, 2004·Psychiatry·Rivka Tuval-MashiachArieh Y Shalev
May 17, 2008·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Juan Angel BellónFrancisco Torres-González
Dec 6, 2012·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Soul Mugerwa, John D Holden
Mar 6, 2007·Patient Education and Counseling·Henriët van MiddendorpRinie Geenen
Mar 29, 2006·Journal of Traumatic Stress·Philip A Burke, Rebekah G Bradley
Aug 1, 2015·Stress and Health : Journal of the International Society for the Investigation of Stress·Christina J JonesHelen E Smith
Oct 22, 2014·Journal of Immigrant and Minority Health·D ElsouhagJ Arnetz
Jan 1, 2010·Journal of College Student Retention : Research, Theory & Practice·Alison M RadcliffeChristina Kraft
Aug 3, 2012·Psychoneuroendocrinology·Daryl B O'ConnorAlexandre Schaefer
Nov 10, 2015·Nursing in Critical Care·Louise C StaytLiz Tutton
Jul 16, 2008·The Australian and New Zealand Journal of Psychiatry·Karen Barton, Chris Jackson
Sep 24, 2014·Qualitative Health Research·Maria Francesca Freda, Maria Luisa Martino
Jul 21, 2007·Journal of Family Nursing·Elaine DuncanJosef Kapelushnik
May 21, 2014·The Cochrane Database of Systematic Reviews·Priyamvada PaudyalHelen E Smith
Jul 20, 2016·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Samuel MalinsRichard Morriss
Sep 7, 2004·The Journal of Nervous and Mental Disease·Pasquale G FrisinaStephen J Lepore
Mar 24, 2005·Psychosomatic Medicine·Joan E BroderickJoseph E Schwartz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.